Logo

Pulmonary Fibrosis Treatment Market Size, Share, Growth, and Regional Forecast, 2025 to 2032

Pulmonary Fibrosis Treatment Market by Drug (Pirfenidone, Nintedanib, Others), Route of Administration (Oral , Injectable), Indication (Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis (PPF), Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) , and Regional Analysis from 2025 to 2032

ID: PMRREP30070
Calendar

November 2025

188 Pages

Author : Abhijeet Surwase

Healthcare
  1. Executive Summary
    1. Global Pulmonary Fibrosis Treatment Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Regulatory Landscape
    2. Product Adoption Analysis
    3. Value Chain Analysis
    4. Key Deals and Mergers
    5. PESTLE Analysis
    6. Porter’s Five Force Analysis
  4. Global Pulmonary Fibrosis Treatment Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
    3. Global Pulmonary Fibrosis Treatment Market Outlook: Drug
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Drug, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2025 - 2032
        1. Pirfenidone
        2. Nintedanib
        3. Others
      4. Market Attractiveness Analysis: Drug
    4. Global Pulmonary Fibrosis Treatment Market Outlook: Route of Administration
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Route of Administration, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
        1. Oral
        2. Injectable
      4. Market Attractiveness Analysis: Route of Administration
    5. Global Pulmonary Fibrosis Treatment Market Outlook: Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
        1. Idiopathic Pulmonary Fibrosis (IPF)
        2. Progressive Pulmonary Fibrosis (PPF)
        3. Others
      4. Market Attractiveness Analysis: Indication
    6. Global Pulmonary Fibrosis Treatment Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      4. Market Attractiveness Analysis: Distribution Channel
  5. Global Pulmonary Fibrosis Treatment Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
    3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Pulmonary Fibrosis Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug
      3. By Route of Administration
      4. By Indication
      5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2025 - 2032
      1. Pirfenidone
      2. Nintedanib
      3. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Oral
      2. Injectable
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Idiopathic Pulmonary Fibrosis (IPF)
      2. Progressive Pulmonary Fibrosis (PPF)
      3. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  7. Europe Pulmonary Fibrosis Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug
      3. By Route of Administration
      4. By Indication
      5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2025 - 2032
      1. Pirfenidone
      2. Nintedanib
      3. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Oral
      2. Injectable
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Idiopathic Pulmonary Fibrosis (IPF)
      2. Progressive Pulmonary Fibrosis (PPF)
      3. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  8. East Asia Pulmonary Fibrosis Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug
      3. By Route of Administration
      4. By Indication
      5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2025 - 2032
      1. Pirfenidone
      2. Nintedanib
      3. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Oral
      2. Injectable
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Idiopathic Pulmonary Fibrosis (IPF)
      2. Progressive Pulmonary Fibrosis (PPF)
      3. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  9. South Asia & Oceania Pulmonary Fibrosis Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug
      3. By Route of Administration
      4. By Indication
      5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2025 - 2032
      1. Pirfenidone
      2. Nintedanib
      3. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Oral
      2. Injectable
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Idiopathic Pulmonary Fibrosis (IPF)
      2. Progressive Pulmonary Fibrosis (PPF)
      3. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  10. Latin America Pulmonary Fibrosis Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug
      3. By Route of Administration
      4. By Indication
      5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2025 - 2032
      1. Pirfenidone
      2. Nintedanib
      3. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Oral
      2. Injectable
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Idiopathic Pulmonary Fibrosis (IPF)
      2. Progressive Pulmonary Fibrosis (PPF)
      3. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  11. Middle East & Africa Pulmonary Fibrosis Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug
      3. By Route of Administration
      4. By Indication
      5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2025 - 2032
      1. Pirfenidone
      2. Nintedanib
      3. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Oral
      2. Injectable
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Idiopathic Pulmonary Fibrosis (IPF)
      2. Progressive Pulmonary Fibrosis (PPF)
      3. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. F. Hoffman - La Roche Ltd.
        1. Overview
        2. Segments and Products
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Boehringer Ingelheim
      3. International GmbH
      4. Cipla Ltd
      5. MediciNova, Inc.
      6. Intas Pharmaceuticals Ltd.
      7. Others
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
Emailsales@persistencemarketresearch.com
UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
USA

Regional Office

Persistence Market Research

108 W 39th Street, Ste 1006,PMB2219, New York, NY 10018

+1 646-878-6329
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

IT Unit No. 504, 5th Floor, IconTower, Baner, Pune - 411045.

+91 906 779 3500
Quick Links
CareersTerms & ConditionsReturn Policy Market Research Report
Customer FAQ’sPrivacy Policy Sitemap

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -